Atlas Trials

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Clinical trial NCT01372579 · UNKNOWN

Trial details

NCT number
NCT01372579
Sponsor
Northwestern University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerMale Breast CancerProgesterone Receptor-negative Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerTriple-negative Breast Cancer
Start date
2011-08-01
Primary completion
2020-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.